RUNX1 and acute lymphoblastic leukemia: To better understand the influence of enhancer usage in ALL, we first identified extensive transcriptional heterogeneity in ETV6::RUNX1, DUX4/ERG, and hyperdiploidy B-cell ALL (B-ALL) primary patient samples, and linked this to novel open chromatin regions that are most likely enhancers.